surmount-1 tirzepatide obesity nejm 2022 weight loss percent Tirzepatide: In the trial, reduction percentages were dose-dependent: 5 mg: ~15.0% weight reduction. 10 mg: ~19.5% weight reduction. 15 mg: ~20.9% weight reduction (Jastreboff et al., 2022). https://www.nejm.org/doi/10.1056 NEJM: Once-Weekly Semaglutide in Adults

Advanced Laser Skin Tightening Treatments In addition to dermal fillers, our laser skin tightening options offer an effective, non-surgical way to firm the skin

These adverse effects are typically mild to moderate and tend to decrease over time

The first four to eight weeks For most people, the most intense fatigue occurs during the first 4 to 8 weeks of treatment

Im sure there are opportunities to speak with your doctor once you get approved

Advise patients using oral hormonal contraceptives to switch to a non-oral contraceptive method, or add a barrier method of contraception for 4 weeks after initiation and for 4 weeks after each dose escalation with MOUNJARO